arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ARROWHEAD PHARMACEUTICALS, INC.

ARWR

$87.66 ▲ +1.86 (+2.17%) at close

23 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

ARROWHEAD PHARMACEUTICALS, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $11.7B

Dividend Yield —

Revenue Growth 23258.2% ↗

Op. Margin 11.9%

ROIC 12.3% ↗

FCF / Share $1.17 ↗

Trailing P/E —

Price / Book 25.5x

FCF Yield 1.3%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

23-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$829.45M

↑ +23258.2% —

Net Income Profit after all expenses

$-1.63M

↑ +99.7% —

Operating Margin Operating profit as % of sales

11.9%

↑ +113.9% 61th

FCF / Share Free cash flow per share

$1.17

↑ +123.2% —

Health Breakdown

Profitability ↑

Returns ↑

Financial Health

100

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗	FY 2008 Sep 30, 2008 10-K ↗	FY 2007 Sep 30, 2007 10-K ↗	FY 2006 Sep 30, 2006 10-K ↗	FY 2005 Sep 30, 2005 10-K ↗	FY 2004 Sep 30, 2004 10-K ↗	FY 2003 Sep 30, 2003 10-K ↗
Revenue Growth YoY (%)	23258.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+290627%)	-98.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1332%)	-1.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-113%)	75.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+849%)	57.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+614%)	-47.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-698%)	945.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11721%)	-48.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-708%)	19736.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+246606%)	-58.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-832%)	118.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1379%)	-39.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-596%)	-93.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1262%)	1297.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+16120%)	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	99.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-160.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-15.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-22.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-61.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—	—	-331.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	51.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	99.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-192.0% Weak ↓ Weak Declining Year-over-year change in net income	-16.6% Weak ↑ Weak Improving Year-over-year change in net income	-25.0% Weak Weak Year-over-year change in net income	-66.6% Weak Weak Year-over-year change in net income	N/M	N/M	-58.4% Weak ↓ Weak Declining Year-over-year change in net income	57.9% Excellent ↑ Excellent Improving Year-over-year change in net income	11.1% Fair ↑ Fair Improving Year-over-year change in net income	-56.8% Weak ↑ Weak Improving Year-over-year change in net income	-88.3% Weak ↑ Weak Improving Year-over-year change in net income	76.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-4209.3% Weak ↓ Weak Declining Year-over-year change in net income	45.8% Excellent ↑ Excellent Improving Year-over-year change in net income	70.1% Excellent ↑ Excellent Improving Year-over-year change in net income	29.1% Excellent ↑ Excellent Improving Year-over-year change in net income	11.3% Fair ↑ Fair Improving Year-over-year change in net income	-53.9% Weak ↑ Weak Improving Year-over-year change in net income	-196.5% Weak ↑ Weak Improving Year-over-year change in net income	-796.3% Weak Weak Year-over-year change in net income	-688.8% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	N/M	-62.9% Weak Weak Year-over-year change in free cash flow	-72.8% Weak Weak Year-over-year change in free cash flow	N/M	N/M	N/M	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	50.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-70.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	39.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	12.9% Good ↓ Good Declining Compound annual revenue growth over 3 years	104.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	41.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	921.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	248.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	464.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-18.3% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-54.8% Weak Weak Compound annual revenue growth over 3 years	-16.1% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	56.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-53.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	71.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	50.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	287.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	196.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	295.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	123.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	50.0% Excellent Excellent Compound annual revenue growth over 5 years	-11.8% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗	FY 2008 Sep 30, 2008 10-K ↗	FY 2007 Sep 30, 2007 10-K ↗	FY 2006 Sep 30, 2006 10-K ↗	FY 2005 Sep 30, 2005 10-K ↗	FY 2004 Sep 30, 2004 10-K ↗	FY 2003 Sep 30, 2003 10-K ↗
Operating Margin (%) (%)	11.9% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-21%)	—	-85.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-668%)	-73.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-589%)	-107.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-818%)	-105.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-806%)	36.3% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+142%)	-346.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2410%)	-117.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-885%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	41.6% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-0.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-102%)	—	-85.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-811%)	-72.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-703%)	-101.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-949%)	-96.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-901%)	40.3% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+236%)	-337.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2911%)	-109.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1012%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	18.9% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-137.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-77.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	106.8% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-122.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	95.4% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-301.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-101.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	-96.19x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.61x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-1.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.27x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	2.37x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗	FY 2008 Sep 30, 2008 10-K ↗	FY 2007 Sep 30, 2007 10-K ↗	FY 2006 Sep 30, 2006 10-K ↗	FY 2005 Sep 30, 2005 10-K ↗	FY 2004 Sep 30, 2004 10-K ↗	FY 2003 Sep 30, 2003 10-K ↗
Return on Invested Capital (%)	12.3% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-322.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-76.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-45.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	25.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-58.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-45.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-85.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-87.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-32.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-70.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-924.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-60.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-50.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—
Return on Capital (%) (%)	7.1% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	-52.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	17.5% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-50.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-35.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-63.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-72.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-65.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-709.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-61.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-47.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-0.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-102%)	—	-75.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-604%)	-44.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-395%)	-34.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-330%)	-18.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-222%)	27.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+85%)	-56.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-479%)	-42.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-381%)	-85.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-670%)	-83.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-656%)	-35.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-335%)	-113.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-855%)	—	-24.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	-63.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-526%)	—	—	—	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗	FY 2008 Sep 30, 2008 10-K ↗	FY 2007 Sep 30, 2007 10-K ↗	FY 2006 Sep 30, 2006 10-K ↗	FY 2005 Sep 30, 2005 10-K ↗	FY 2004 Sep 30, 2004 10-K ↗	FY 2003 Sep 30, 2003 10-K ↗
Interest Coverage (x)	5176.11x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—	-11.19x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	2230.22x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-322.62x Weak Weak Operating income divided by interest expense Optimal: > 5x	-197.16x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-251.14x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-256.02x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	—	—	—	—	—	$-143.58M	$-221.80M	$-30.13M	$-24.84M	$-85.37M	$-81.21M	$-132.51M	$-19.11M	$-3.38M	$-7.51M	$-6.85M	$-2.02M	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗	FY 2008 Sep 30, 2008 10-K ↗	FY 2007 Sep 30, 2007 10-K ↗	FY 2006 Sep 30, 2006 10-K ↗	FY 2005 Sep 30, 2005 10-K ↗	FY 2004 Sep 30, 2004 10-K ↗	FY 2003 Sep 30, 2003 10-K ↗
Revenue per Share (USD)	$6.20	$0.03	$2.26	$2.31	$1.33	$0.87	$1.80	$0.19	—	—	—	—	—	$3.72	$0.41	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.01	$-5.00	$-1.92	$-1.67	$-1.36	$-0.84	$0.72	$-0.65	—	—	—	—	—	$-19.00	$-4.40	$-9.00	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$1.17	$-5.05	$-3.10	$-1.79	$1.42	$-1.07	$1.72	$-0.58	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$3.43	$1.49	$2.53	$3.76	$3.92	$4.51	$2.56	$1.08	$1.09	$1.37	$1.85	$3.05	$0.85	$7.37	$14.80	$12.61	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$3.43	$1.49	$2.53	$3.76	$3.92	$4.51	$2.56	$1.08	$1.09	$1.05	$1.43	$3.03	$0.75	$7.37	$14.80	$12.61	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	133.76M	119.78M	106.75M	105.43M	103.75M	100.72M	93.86M	83.64M	—	—	—	—	—	1.11M	718,112	643,424	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗	FY 2008 Sep 30, 2008 10-K ↗	FY 2007 Sep 30, 2007 10-K ↗	FY 2006 Sep 30, 2006 10-K ↗	FY 2005 Sep 30, 2005 10-K ↗	FY 2004 Sep 30, 2004 10-K ↗	FY 2003 Sep 30, 2003 10-K ↗
Working Capital (USD)	$755.15M	$592.30M	$314.06M	$266.45M	$238.06M	$281.69M	$168.18M	$66.40M	$49.20M	$64.86M	$86.97M	$142.95M	$20.12M	$1.24M	$7.28M	$3.86M	—	—	—	—	—	—	—
Total Equity (USD)	$466.05M	$185.44M	$271.34M	$398.52M	$408.82M	$461.78M	$244.59M	$95.80M	$81.42M	$95.58M	$110.18M	$166.54M	$27.50M	$10.01M	$12.79M	$9.05M	—	—	—	—	—	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Sep 30, 2017 10-K ↗	FY 2016 Sep 30, 2016 10-K ↗	FY 2015 Sep 30, 2015 10-K ↗	FY 2014 Sep 30, 2014 10-K ↗	FY 2013 Sep 30, 2013 10-K ↗	FY 2012 Sep 30, 2012 10-K ↗	FY 2011 Sep 30, 2011 10-K ↗	FY 2010 Sep 30, 2010 10-K ↗	FY 2009 Sep 30, 2009 10-K ↗	FY 2008 Sep 30, 2008 10-K ↗	FY 2007 Sep 30, 2007 10-K ↗	FY 2006 Sep 30, 2006 10-K ↗	FY 2005 Sep 30, 2005 10-K ↗	FY 2004 Sep 30, 2004 10-K ↗	FY 2003 Sep 30, 2003 10-K ↗
Sales/Revenue/Turnover (USD)	$829.45M	$3.55M	$240.74M	$243.23M	$138.29M	$87.99M	$168.80M	$16.14M	$31.41M	$158.33K	$382.00K	$175.00K	$290.27K	$4.14M	$296.14K	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$22.20M	$16.90M	$10.70M	$8.70M	$6.60M	$4.24M	$2.74M	$3.00M	$2.99M	—	—	$1.35M	$1.75M	$7.41M	$267.98K	$277.65K	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-1.63M	$-599.49M	$-205.28M	$-176.06M	$-140.85M	$-84.55M	$67.97M	$-54.45M	$-34.38M	$-81.72M	$-91.94M	$-58.63M	$-31.14M	$-134.83M	$-3.13M	$-5.77M	$-19.31M	$-27.24M	$-30.71M	$-19.96M	$-6.73M	$-751.25K	$-95.24K
Operating Cash Flow (USD)	$179.55M	$-462.85M	$-153.89M	$-136.13M	$171.31M	$-95.39M	$173.03M	$-47.22M	$-23.94M	—	—	—	—	—	—	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 23 years · 83 quarters

ARROWHEAD PHARMACEUTICALS, INC.

Analytical Summary

23-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare ARWR with peers